Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules MSN/2024/051 Tier 3 high impact Date of issue: 8th May 2024 All strengths of Elvanse® capsules are now available and an improved level of supply will continue across the majority of Elvanse® and Elvanse Adult® presentations. There will
Read moreEli Lilly and Company (Lilly) in agreement with the Medicines and Healthcare product Regulatory Agency (MHRA) has announced an extension to the shelf-life of Mounjaro®▼ (tirzepatide) 2.5mg KwikPen® from 9 months to 14 months for the following batches : Product Batch No. Displayed/Printed Expiry Date New Expiry Date Dear Patient Letter link Mounjaro® 2.5mg KwikPen®
Read moreSince the launch of the service, Community Pharmacy England and NHS England have published a number of resources to support pharmacy owners and their teams to promote the Pharmacy First service. We have incorporated all of these into a Pharmacy First checklist so pharmacy owners can work through the checklist to see if there are
Read moreCommunity Pharmacy England will shortly be asking pharmacy owners and their teams to help us measure the increasing number of people relying on pharmacies. Years of financial and operational pressures are continuing to take their toll on the sector, with many community pharmacy businesses being pushed to the brink. Whilst the £645m recovery plan funding
Read moreIn light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed. Community pharmacists should no longer supply antiviral medicines
Read moreFollowing the changes to pack sizes for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension, six more products that require reconstitution have had their pack sizes updated in the NHS dictionary of medicines and devices (dm+d) and the Drug Tariff from May 2024. This follows the identification by Community Pharmacy England of pack size listing discrepancies
Read moreThe Department of Health and Social Care (DHSC) has today (01/05/2024) confirmed the following final list of price concessions for April 2024. This final update comes after the end of the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April to try to manage
Read moreThe public is receptive to Pharmacy First but more needs to be done to increase awareness of and further develop pharmacy services, a new report from Healthwatch England finds. The ‘Pharmacy: what people want‘ report, published today (30th April), calls on the Government to issue targeted communications to raise awareness of the Pharmacy First service,
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) Montelukast: reminder of the risk of neuropsychiatric reactions Letters
Read moreThe NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 55) contains some useful information and advice on: NHS prescription charges from 1 May 2024 Patients reminded to renew their HRT PPC Contractors reminded to use correct prescribing codes FP10 NHS prescription forms: memantine
Read more
